Exact Mass: 1201.8413

Exact Mass Matches: 1201.8413

Found 32 metabolites which its exact mass value is equals to given mass value 1201.8413, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Cyclosporine

Cyclosporine (Neoral)

C62H111N11O12 (1201.8413)


D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D003524 - Cyclosporins D004791 - Enzyme Inhibitors > D065095 - Calcineurin Inhibitors D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents Cyclosporin A (Cyclosporine A) is an immunosuppressant which binds to the cyclophilin and inhibits phosphatase activity of protein phosphatase 2B (PP2B/calcineurin) with an IC50 of 5 nM[3]. Cyclosporin A also inhibits CD11a/CD18 adhesion[8].

   

Cyclosporin A

30-ethyl-33-(1-hydroxy-2-methylhex-4-en-1-yl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone

C62H111N11O12 (1201.8413)


   

(Melle-4)cyclosporin

24-(butan-2-yl)-30-ethyl-33-(1-hydroxy-2-methylhex-4-en-1-yl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone

C62H111N11O12 (1201.8413)


   

Ciclosporin

(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone

C62H111N11O12 (1201.8413)


Cyclosporin a appears as white prismatic needles (from acetone) or white powder. (NTP, 1992) Cyclosporin A is a cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patients immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle. It has a role as an antifungal agent, an antirheumatic drug, a dermatologic drug, an immunosuppressive agent, a metabolite, a carcinogenic agent, an anti-asthmatic drug, an EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor, an anticoronaviral agent and a geroprotector. Cyclosporine is a calcineurin inhibitor known for its immunomodulatory properties that prevent organ transplant rejection and treat various inflammatory and autoimmune conditions. It is isolated from the fungus Beauveria nivea. Initially manufactured by Sandoz and approved for use by the FDA in 1983, cyclosporine is now available in various products by Novartis (previously known as Sandoz). Cyclosporine is a Calcineurin Inhibitor Immunosuppressant. The mechanism of action of cyclosporine is as a Calcineurin Inhibitor, and Cytochrome P450 3A4 Inhibitor, and P-Glycoprotein Inhibitor. Cyclosporine is a calcineurin inhibitor and potent immunosuppressive agent used largely as a means of prophylaxis against cellular rejection after solid organ transplantation. Cyclosporine therapy can be associated with mild elevations in serum bilirubin and transient serum enzyme elevations, and to rare instances of clinically apparent cholestatic liver injury. Ciclosporin is a natural product found in Tolypocladium inflatum and Trichoderma polysporum with data available. Cyclosporine is a natural cyclic polypeptide immunosuppressant isolated from the fungus Beauveria nivea. The exact mechanism of action of cyclosporine is not known but may involve binding to the cellular protein cytophilin, resulting in inhibition of the enzyme calcineurin. This agent appears to specifically and reversibly inhibit immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited with T-helper cells as the primary target. Cyclosporine also inhibits lymphokine production and release. (NCI04) A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patients immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle. L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AD - Calcineurin inhibitors D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D003524 - Cyclosporins C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C146638 - Calcineurin Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D065095 - Calcineurin Inhibitors D000890 - Anti-Infective Agents > D000935 - Antifungal Agents S - Sensory organs > S01 - Ophthalmologicals C1744 - Multidrug Resistance Modulator D018501 - Antirheumatic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Cyclosporin A (Cyclosporine A) is an immunosuppressant which binds to the cyclophilin and inhibits phosphatase activity of protein phosphatase 2B (PP2B/calcineurin) with an IC50 of 5 nM[3]. Cyclosporin A also inhibits CD11a/CD18 adhesion[8].

   
   
   
   
   
   

Cyclosporin A

Cyclosporine A

C62H111N11O12 (1201.8413)


D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D003524 - Cyclosporins D004791 - Enzyme Inhibitors > D065095 - Calcineurin Inhibitors D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents Origin: Microbe; SubCategory_DNP: Peptides, Cyclic peptides, Cyclosporins Cyclosporin A (Cyclosporine A) is an immunosuppressant which binds to the cyclophilin and inhibits phosphatase activity of protein phosphatase 2B (PP2B/calcineurin) with an IC50 of 5 nM[3]. Cyclosporin A also inhibits CD11a/CD18 adhesion[8].

   

Cyclosporin H

Cyclosporin H

C62H111N11O12 (1201.8413)


Origin: Microbe; SubCategory_DNP: Peptides, Cyclic peptides, Cyclosporins Cyclosporin H is a selective and potent inhibitor of FPR-1 (formyl peptide receptor 1). Cyclosporin H, a viral transduction enhancer, increases lentiviral transduction up to 10-fold in human cord blood-derived hematopoietic stem and progenitor cells (HSPCs). Cyclosporin H displays an additive effect when combined with Rapamycin (HY-10219) or Prostaglandin E2 (HY-101952). Cyclosporin H lacks immunosuppressant activity of Cyclosporin A.

   
   
   

(Melle-4)cyclosporin

(Melle-4)cyclosporin

C62H111N11O12 (1201.8413)


D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D003524 - Cyclosporins NIM811 ((Melle-4)cyclosporin; SDZ NIM811) is an orally bioavailable mitochondrial permeability transition and cyclophilin dual inhibitor, which exhibits potent in vitro activity against hepatitis C virus (HCV) [1][2].

   

24-butan-2-yl-30-ethyl-33-[(E)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

24-butan-2-yl-30-ethyl-33-[(E)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

C62H111N11O12 (1201.8413)


   

Gengraf

cyclosporine

C62H111N11O12 (1201.8413)


D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D003524 - Cyclosporins D004791 - Enzyme Inhibitors > D065095 - Calcineurin Inhibitors D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents

   

(3s,6s,9s,12r,15s,18s,21s,24s,30s,33s)-30-ethyl-14,17,23,32-tetrahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

(3s,6s,9s,12r,15s,18s,21s,24s,30s,33s)-30-ethyl-14,17,23,32-tetrahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

C62H111N11O12 (1201.8413)


   

14,17,20,23,32-pentahydroxy-33-(1-hydroxy-2-methylhex-4-en-1-yl)-3,21-diisopropyl-1,4,7,10,12,15,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,19,22,31-pentaene-2,5,8,11,26,29-hexone

14,17,20,23,32-pentahydroxy-33-(1-hydroxy-2-methylhex-4-en-1-yl)-3,21-diisopropyl-1,4,7,10,12,15,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,19,22,31-pentaene-2,5,8,11,26,29-hexone

C62H111N11O12 (1201.8413)


   

(6s,9s,12s,15s,18s,21r,24s,27s,30s,33s)-8,17,23,26,32-pentahydroxy-9-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-6,12,30-triisopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,33-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone

(6s,9s,12s,15s,18s,21r,24s,27s,30s,33s)-8,17,23,26,32-pentahydroxy-9-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-6,12,30-triisopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,33-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone

C62H111N11O12 (1201.8413)


   

(3s,6s,9s,12r,15s,18s,21s,24s,30s,33s)-24-[(2s)-butan-2-yl]-30-ethyl-14,17,23,32-tetrahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

(3s,6s,9s,12r,15s,18s,21s,24s,30s,33s)-24-[(2s)-butan-2-yl]-30-ethyl-14,17,23,32-tetrahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

C62H111N11O12 (1201.8413)


   

8,17,23,26,32-pentahydroxy-9-(1-hydroxy-2-methylhex-4-en-1-yl)-6,12,30-triisopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,33-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone

8,17,23,26,32-pentahydroxy-9-(1-hydroxy-2-methylhex-4-en-1-yl)-6,12,30-triisopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,33-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone

C62H111N11O12 (1201.8413)


   

11,14,17,23,32-pentahydroxy-33-(1-hydroxy-2-methylhex-4-en-1-yl)-3,21-diisopropyl-1,4,7,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-10,13,16,22,31-pentaene-2,5,8,20,26,29-hexone

11,14,17,23,32-pentahydroxy-33-(1-hydroxy-2-methylhex-4-en-1-yl)-3,21-diisopropyl-1,4,7,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-10,13,16,22,31-pentaene-2,5,8,20,26,29-hexone

C62H111N11O12 (1201.8413)


   

(3s,6s,9r,12r,15s,18s,21s,24s,30s,33s)-14,17,20,23,32-pentahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,19,22,31-pentaene-2,5,8,11,26,29-hexone

(3s,6s,9r,12r,15s,18s,21s,24s,30s,33s)-14,17,20,23,32-pentahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,19,22,31-pentaene-2,5,8,11,26,29-hexone

C62H111N11O12 (1201.8413)


   

30-ethyl-14,17,23,32-tetrahydroxy-33-(1-hydroxy-2-methylhex-4-en-1-yl)-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

30-ethyl-14,17,23,32-tetrahydroxy-33-(1-hydroxy-2-methylhex-4-en-1-yl)-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

C62H111N11O12 (1201.8413)


   

(3s,6r,9r,12r,15r,18s,24s,30s,33r)-30-ethyl-14,17,23,32-tetrahydroxy-33-[(1s,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

(3s,6r,9r,12r,15r,18s,24s,30s,33r)-30-ethyl-14,17,23,32-tetrahydroxy-33-[(1s,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

C62H111N11O12 (1201.8413)


   

(6s,9s,12s,15s,18r,21r,24s,27s,30s,33s)-8,17,23,26,32-pentahydroxy-9-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-12,30-diisopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,33-tetrakis(2-methylpropyl)-6-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone

(6s,9s,12s,15s,18r,21r,24s,27s,30s,33s)-8,17,23,26,32-pentahydroxy-9-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-12,30-diisopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,33-tetrakis(2-methylpropyl)-6-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone

C62H111N11O12 (1201.8413)


   

(6s,9s,12s,15s,18s,21r,24s,27s,30s,33s)-8,17,23,26,32-pentahydroxy-9-[(1r,2s,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-6,12,30-triisopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,33-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone

(6s,9s,12s,15s,18s,21r,24s,27s,30s,33s)-8,17,23,26,32-pentahydroxy-9-[(1r,2s,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-6,12,30-triisopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,33-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone

C62H111N11O12 (1201.8413)


   

(3r,6s,9s,12r,15s,18s,21s,24s,30s,33r)-30-ethyl-14,17,23,32-tetrahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

(3r,6s,9s,12r,15s,18s,21s,24s,30s,33r)-30-ethyl-14,17,23,32-tetrahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

C62H111N11O12 (1201.8413)


   

8,17,23,26,32-pentahydroxy-9-(1-hydroxy-2-methylhex-4-en-1-yl)-12,30-diisopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,33-tetrakis(2-methylpropyl)-6-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone

8,17,23,26,32-pentahydroxy-9-(1-hydroxy-2-methylhex-4-en-1-yl)-12,30-diisopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,33-tetrakis(2-methylpropyl)-6-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone

C62H111N11O12 (1201.8413)


   

(3r,6s,9s,12r,15s,18s,21s,24s,30s,33s)-11,14,17,23,32-pentahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-10,13,16,22,31-pentaene-2,5,8,20,26,29-hexone

(3r,6s,9s,12r,15s,18s,21s,24s,30s,33s)-11,14,17,23,32-pentahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-10,13,16,22,31-pentaene-2,5,8,20,26,29-hexone

C62H111N11O12 (1201.8413)


   

30-ethyl-14,17,23,32-tetrahydroxy-33-[(4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

30-ethyl-14,17,23,32-tetrahydroxy-33-[(4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

C62H111N11O12 (1201.8413)


   

(3r,6s,9s,12r,15s,18s,21s,24s,30s,33s)-30-ethyl-14,17,23,32-tetrahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

(3r,6s,9s,12r,15s,18s,21s,24s,30s,33s)-30-ethyl-14,17,23,32-tetrahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone

C62H111N11O12 (1201.8413)